Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

R.P. Riechelmann, V. Srimuninnimit, R. Bordonaro, P. Kavan, M. Di Bartolomeo, E. Maiello, I. Cicin, P. García-Alfonso, I. Chau, M.Y. Fedyanin, C.F. Martos, M. Ter-Ovanesov, M. Peeters, Y.-J. Ko, S. Yalcin, M. Karthaus, J. Aparicio, V. Heinemann, P. Picard, D. BuryE. Drea, A. Sobrero

Research output: Contribution to journalArticlepeer-review

Cite this